BARD1 Life Sciences Limited announced the appointment of Dr. Samuel Janes, as a member of its Advisory Board. Dr. Samuel Janes MBBS MRCP MSc PhD is an outstanding clinical scientist, respiratory physician, and a Wellcome Senior Fellow in Clinical Science, Professor of Respiratory Medicine and Head of Respiratory Research Department at the University College London Hospitals. Dr. Janes is recognised internationally for his research into lung cancer, mesothelioma, bronchoscopy and early lung cancer detection. He is a lead investigator in several diagnostic and therapeutic clinical studies in lung cancer, and is strongly committed to facilitating the translation of laboratory findings into the clinic. He has published over 100 clinical and scientific papers in the field of respiratory disease, and has sat on the British Thoracic Society, British Lung Foundation, and Roy Castle Lung Cancer Foundation scientific committees. He was awarded the European Thoracic Oncology Investigator of the Year in 2010.